Skip to main content

Table 3 Study of the degree of improvement in each function with Episil®

From: Efficacy of Episil® in patients with hematologic malignancies: a comparative study

  1. In all the categories, the patients' performance did not decline after the drug was administered compared to their performance before taking the medication
Back to article page

BMC Oral Health

ISSN: 1472-6831

Contact us